Cell membrane penetration and mitochondrial targeting by platinum-decorated ceria nanoparticles† by Torrano, Adriano A. et al.
Nanoscale
PAPER
Cite this: Nanoscale, 2016, 8, 13352
Received 27th November 2015,
Accepted 10th June 2016
DOI: 10.1039/c5nr08419a
www.rsc.org/nanoscale
Cell membrane penetration and mitochondrial
targeting by platinum-decorated ceria
nanoparticles†
Adriano A. Torrano,a,b Rudolf Herrmann,c Claudia Strobel,d Markus Rennhak,c
Hanna Engelke,a Armin Reller,e Ingrid Hilger,d Achim Wixforthb,c and
Christoph Bräuchle*a,b
In this work we investigate the interaction between endothelial cells and nanoparticles emitted by cata-
lytic converters. Although catalyst-derived particles are recognized as growing burden added to environ-
mental pollution, very little is known about their health impact. We use platinum-decorated ceria
nanoparticles as model compounds for the actual emitted particles and focus on their fast uptake and
association with mitochondria, the cell’s powerhouse. Using live-cell imaging and electron microscopy
we clearly show that 46 nm platinum-decorated ceria nanoparticles can rapidly penetrate cell membranes
and reach the cytosol. Moreover, if suitably targeted, these particles are able to selectively attach to mito-
chondria. These results are complemented by cytotoxicity assays, thus providing insights into the biologi-
cal effects of these particles on cells. Interestingly, no permanent membrane disruption or any other
significant adverse effects on cells were observed. The unusual uptake behavior observed for 46 nm
nanoparticles was not observed for equivalent but larger 143 nm and 285 nm platinum-decorated par-
ticles. Our results demonstrate a remarkable particle size effect in which particles smaller than
∼50–100 nm escape the usual endocytic pathway and translocate directly into the cytosol, while particles
larger than ∼150 nm are internalized by conventional endocytosis. Since the small particles are able to
bypass endocytosis they could be explored as drug and gene delivery vehicles. Platinum-decorated nano-
particles are therefore highly interesting in the fields of nanotoxicology and nanomedicine.
1. Introduction
Particle pollution is made up of extremely small liquid dro-
plets and solid particles from a variety of components, includ-
ing acids, organic compounds, soot, dust and metals.1
Exposure to particle pollution has been associated with a
number of respiratory, cardiovascular and neurologic
diseases.2–5 Notably, particle pollution has recently been
classified as carcinogenic to humans,6 and outdoor air pol-
lution has been pointed as a leading cause of cancer deaths.7
With regard to the size distribution in the ambient atmo-
spheric environment, particles <300 nm represent more than
99% of the total number concentration.8 Globally, the main
source of nano-sized particles in urban air is motor traffic.3,9
In order to mitigate the emission of particles and other
dangerous substances from the engine, modern vehicles are
equipped with catalytic converters. Automobile catalytic con-
verters are able to transform more than 90% of total unburned
hydrocarbons, carbon monoxide, and nitrogen oxides into
rather harmless compounds, such as carbon dioxide, nitrogen
and water. On the whole, they consist of a porous carrier
material (e.g. CeO2, or ceria) that is decorated with active noble
metals (normally platinum, but also palladium and rhodium).
Although playing a fundamental role in reducing the emission
of pollutants from vehicles, catalytic converters decompose
with time and generate new particle emissions in the nano-
and micrometer ranges. Catalyst-derived particles consisting of
a carrier material and decorated with noble metals are thus
formed and released into the environment.10–17 As a result of
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the escalating traffic worldwide, the concentration of noble
metals (free or bound to the carrier material) has been increas-
ing in urban areas. Wichmann et al.17 reported that the concen-
tration of catalyst-derived platinum in the air of Braunschweig
City (Germany) jumped from 6.0 pg m−3 in 1999 to 159 pg m−3
in 2005. Nanoparticles (NPs) generated by catalytic converters
are therefore a growing burden added to particle pollution.
Since very little is known about the health impact of cata-
lyst-derived NPs, our goal in this work is to investigate the bio-
logical effect of these NPs at the cellular level. Studying the
interaction of catalyst-derived NPs with biological systems
directly is hardly possible due to the low concentrations in
samples like road dust. For this purpose, reasonable quantities
of model compounds that resemble the actual catalyst-derived
NPs were synthesized.18 Our mimetic compounds consist of a
ceria NP core (defined sizes between 8 and 285 nm) decorated
with ultrasmall platinum NPs (2–5 nm). The interaction
between platinum-decorated ceria nanoparticles (Pt-ceria NPs)
and human microvascular endothelial cells (HMEC-1) was
studied in detail by live-cell imaging. Inhalation, skin contact,
and ingestion are the main routes for NPs to enter the human
body.19 In all three cases NPs can reach the bloodstream,
where they can interact with endothelial cells covering the
inner surface of blood vessels.20,21 These cells play a crucial
role in the process of blood flow, while changes in endo-
thelium are often found in a number of diseases.22–25 There-
fore, endothelial cell lines represent an important model
system to investigate the bioactivity and cellular uptake of NPs.
In addition, we investigated if the same uptake behavior would
be found in other cell types, such as human cervical cancer
cells (HeLa). Surprisingly, Pt-ceria NPs of specific character-
istics were rapidly found inside living cells and selectively
associated with mitochondria. These exciting findings focused
our investigations on the biological effects related to the
unusual fast NP uptake mechanism as well as the mitochon-
drial-targeting properties of the model compounds.
Several mechanisms for the cellular uptake via endocytosis
have been discussed in the literature. The most relevant and
better understood mechanisms are clathrin-mediated endo-
cytosis, caveolin-mediated endocytosis, macropinocytosis, and
phagocytosis.26–28 Interestingly, cell-penetrating peptides,29
CdSe/ZnS core/shell quantum dots (8 nm, coated with D-peni-
cillamine),30 and ultrasmall noble metal NPs (typically smaller
than ∼10 nm), such as gold,31–35 and platinum,36,37 can escape
the traditional endocytosis pathway and perform a fast direct
translocation across the cell membrane into the cytosol. This
unconventional uptake mechanism is characterized by fast
and efficient cellular uptake, no perceptible cell membrane
disruption and low cytotoxic effects.31 Although often
reported, the mechanism of cell membrane penetration is not
fully understood. Using coarse-grained molecular dynamics
simulations, Lin and Alexander-Katz31 proposed that cell mem-
branes generate nanoscale transient holes to assist the fast
and spontaneous translocation of cell-penetrating peptides as
well as ultrasmall cationic NPs into the cytoplasm. According
to this model, when ultrasmall cationic NPs (e.g. 2.2 nm gold
particles) approach the membrane, they are attracted to nega-
tively charged membrane proteins. Once a certain number of
NPs are located in the membrane region, nanoscale holes are
formed due to the alteration of the local electric field across
the plasma membrane. NPs that are already in the region will
then use these holes to directly translocate into the cytosol.
After translocation, the transmembrane potential is strongly
reduced and the membrane rapidly reseals itself. In this
context, delivery of payloads by NPs that are able to rapidly
enter cells and accumulate in organelles has great potential to
advance the treatment of many disorders. The interaction of
Pt-ceria NPs with cells is therefore highly interesting with
respect to the two complementary fields of nanotoxicology and
nanomedicine. On the one hand, it plays an important role in
the toxicology of nanomaterials and particle pollution; on the
other hand, it can help to deliver therapeutics directly to mito-
chondria in the field of drug delivery and nanomedicine.
2. Results and discussion
2.1 Characterization of Pt-ceria NPs
A reproducible method for the synthesis of platinum-decorated
ceria NPs that resemble those emitted from catalytic converters
was developed and published in the literature by Herrmann
et al.18 Basically, the model compounds are made up of a ceria
NP core of defined sizes (between 8 and 285 nm) decorated with
ultrasmall platinum NPs (2–5 nm). Particles are labeled with co-
valently-bound fluorophores (Atto 647N or perylenediimide) to
allow the detection by fluorescence microscopy techniques.
Labeling was performed with modified dyes containing trietho-
xysilyl groups. These groups react and form covalent bonds with
the hydroxyl moieties commonly present at the surface of ceria
and other oxidic nanoparticles.18 The fluorescent dye precursor
(size <2 nm) is thus connected to terminal OH groups at the
CeO2 surface through a transesterification reaction.
The size and shape of the model compounds synthesized
for our investigations were characterized by transmission elec-
tron microscopy (TEM) measurements. Fig. 1 shows the TEM
images of 8 nm ceria NPs decorated with platinum and
labeled with Atto 647N (Pt-Ceria-8-atto). The primary particle
size was determined by image analysis of TEM micrographs. In
addition, energy-dispersive X-ray (EDX) spectroscopy (Fig. 1C)
was used to prove the elemental composition of the model par-
ticles, with platinum (in blue) deposited on ceria NP cores
(cerium in red).
Airborne NPs, like those released by automobile catalytic
converters, tend to form aggregates in the nano- and
micrometer ranges. A comparable tendency towards aggrega-
tion was observed during the synthesis of our model com-
pounds. Large and irregular aggregates of Pt-Ceria-8-atto NPs
of different sizes and shapes can be easily identified in Fig. 1.
The aggregation of particles was further characterized by
dynamic light scattering (DLS) measurements of NPs dispersed
in ethanol, the solvent in which particles were synthesized, as
well as in cell medium supplemented with 10% FBS (fetal
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bovine serum). DLS measurements of the Pt-Ceria-8-atto NPs
revealed a mean hydrodynamic diameter of 129 nm in ethanol
and 246 nm in cell medium, with relatively broad size distri-
butions (PDIs = 0.121 and 0.258, respectively). Analogous
model compounds of 8 nm Pt-ceria NPs were prepared and
labeled with a perylenediimide-derived dye with a triethoxysilyl
anchor group (sample Pt-Ceria-8-pery).18 The mean hydro-
dynamic size of the Pt-Ceria-8-pery NPs was determined to be
154 nm (PDI = 0.116) in ethanol and 229 nm in cell medium
(PDI = 0.506). The results are summarized in Table 1.
On the one hand, it is desirable to investigate the inter-
action of model compounds that closely resemble not only the
composition but also the aggregation behavior of actual cata-
lyst-derived NPs. On the other hand, it is of paramount impor-
tance to find out whether model compounds of different sizes
would have distinct biological effects. Ideal samples to investi-
gate particle-size dependent cellular responses should thus
have very narrow size distributions. To accomplish this task we
developed a strategy to synthesize Pt-ceria NP samples with
reasonable monodisperse size distributions (i.e. PDI <0.1). The
method is based on using polyvinylpyrrolidone (PVP), a
surface-active reagent, to obtain the aggregation control of
8 nm ceria NPs during the synthesis.18 This means that NP
aggregation is not avoided, but rather controlled. Fig. 2 shows
representative TEM images of stable, uniform and almost
spherical aggregates achieved by using this strategy. Ceria NPs
of 8 nm are the building blocks to form new NPs of 47 nm
(Ceria-47-atto, Fig. 2A). Nearly spherical ceria NP aggregates
are the ideal starting material for mimetic catalyst-derived NPs
Fig. 2 TEM images of ceria and Pt-ceria NPs of different sizes. Electron
micrographs of (A) non-decorated ceria NPs with a mean size of 47 nm,
(B) platinum-decorated ceria NPs of 46 nm, (C) 143 nm, and (D) 285 nm.
Fig. 1 TEM and EDX images of 8 nm ceria NPs decorated with platinum
(Pt-Ceria-8-atto). (A) Electron micrograph of Pt-Ceria-8-atto NPs.
Strong aggregation of model compounds resembling the actual cata-
lyst-derived NPs found in the environment. (B) Representative aggregate
of Pt-Ceria-8-atto NPs. (C) EDX mapping of the same region in (B). This
technique was used to confirm the deposition of platinum (blue) on
ceria NP cores (red).















Pt-Ceria-8-atto Atto 647N 8 n.d. f 129 246 0.121 0.258 +35.1 −7.6
Pt-Ceria-8-pery Perylenediimide 8 n.d. f 154 229 0.116 0.506 +27.1 −10.8
Ceria-47-atto Atto 647N 8 47 110 158 0.096 0.486 +36.4 −6.5
Pt-Ceria-46-atto Atto 647N 8 46 103 135 0.157 0.372 +45.9 −7.4
Pt-Ceria-143-atto Atto 647N 8 143 167 173 0.020 0.340 +35.3 −10.0
Pt-Ceria-285-atto Atto 647N 8 285 292 428 0.060 0.172 +49.2 −10.6
a Particle diameter measured by transmission electron microscopy (TEM). bMean hydrodynamic diameter determined by dynamic light scatter-
ing (DLS) measurements. c Particle dispersion in ethanol. d Particle dispersion incubated for 30–40 min in cell medium supplemented with 10%
FBS. e Polydispersity index (PDI) is a width parameter describing the hydrodynamic particle size distribution. Shortly, PDI <0.1 indicates mono-
disperse samples with narrow size distributions, PDI between 0.1 and 0.5 characterizes a relatively broad size distribution, and PDI >0.5 points to
polydisperse samples with broad size distributions. fNot determined.
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of defined core sizes and decorated with platinum. By using
this procedure, Pt-decorated ceria NPs of three different core
sizes were produced: 46 nm (Pt-Ceria-46-atto), 143 nm
(Pt-Ceria-143-atto), and 285 nm (Pt-Ceria-285-atto). The TEM
images of these particles are shown in Fig. 2B–D, respectively.
DLS measurements revealed the hydrodynamic diameter
and the PDI values of the new samples. The results presented
in Table 1 show that reasonable narrow size distributions were
achieved. Ceria-47-atto and Pt-Ceria-46-atto, the smaller model
compounds, still presented a tendency to increase their sizes
by clustering with neighboring aggregates in a process that
can be termed super-aggregation (Fig. 2A and B). This is
directly reflected by the mean hydrodynamic sizes/PDI of these
samples dispersed in ethanol: 110 nm/0.096 for Ceria-47-atto
NPs and 103 nm/0.157 for Pt-Ceria-46-atto NPs. Even more
satisfactory results were obtained with the larger model com-
pounds Pt-Ceria-143-atto and Pt-Ceria-285-atto. Very small PDI
values were achieved and the mean hydrodynamic sizes were
just slightly larger than those measured by TEM (as expected,
due to hydration and solvation effects). The mean hydro-
dynamic sizes/PDI in ethanol were determined to be 167 nm/
0.020 for Pt-Ceria-143-atto NPs and 292 nm/0.060 for Pt-Ceria-
285-atto NPs.
The transfer of ceria and Pt-ceria NPs from ethanol into cell
medium, while avoiding the formation of large aggregates and
super-aggregates, was a considerable challenge. In many cases,
the traditional method to redisperse NPs (centrifugation fol-
lowed by washing steps and a final redispersion in water)
failed completely. Using this procedure, aggregates in the
micrometer range were often formed and could not be broken
down again to the original particle sizes. Importantly, in such
cases cell membrane penetration by aggregated Pt-ceria NPs
was not detected. In fact, this was the first hint that led us to
explore the strong particle size-dependent effect in the uptake
behavior of Pt-ceria NPs. After innumerous trials with different
conditions and methods, an efficient and yet simple procedure
was designed. Shortly, a small aliquot of well-dispersed NPs in
ethanol is added into a microreaction tube; ethanol is left to
evaporate; dried NPs are then redispersed directly in cell
medium (see details in section 3.2). The final NP dispersion in
cell medium, prepared as just described, maintained the par-
ticles closer to their original sizes. Importantly, NPs smaller
than ∼50–100 nm were still present after redispersion, as indi-
cated overall by the remarkable and consistent particle-size
dependent uptake behavior of Pt-ceria NPs.
The surface charge, or zeta potential, of all samples dis-
persed in either ethanol (after synthesis) or in cell medium
supplemented with 10% FBS was determined based on electro-
phoretic mobility measurements (Table 1). Positive surface
charges with comparable magnitudes were measured in all
samples dispersed in ethanol, with values ranging from
+27.1 mV for Pt-Ceria-8-pery NPs to +49.2 mV for Pt-Ceria-285-
atto NPs. The zeta potential values of all samples dispersed in
cell medium were also found to be similar to each other, with
negative values ranging from −10.8 mV for Pt-Ceria-8-pery to
−6.5 eV for Ceria-47-atto. These results indicate that zeta
potential values were not considerably altered by labeling,
platinum decoration, or differences in the primary particle
size. Therefore, all samples used in this study have a compar-
able net surface charge that, as expected, will mainly depend
on the dispersion medium.
2.2 Uptake kinetics and intracellular fate of Pt-ceria NPs
The cellular uptake of catalyst-derived model NPs was investi-
gated by live-cell imaging. Basically, endothelial cells
(HMEC-1) were incubated with cell culture medium containing
20–100 µg mL−1 of ceria or Pt-ceria NPs under controlled con-
ditions and imaged live afterwards.
The very first uptake experiments in which HMEC-1 cells
were incubated with Pt-Ceria-8-atto NPs revealed remarkable
results: NPs were rapidly internalized by cells and were found
selectively attached to mitochondria. As depicted in Fig. 3A, a
substantial amount of Pt-Ceria-8-atto NPs is found associated
with mitochondria after just 10 min of incubation time. Deter-
mination of Manders’ overlap coefficient38 revealed that as
much as 91% of NPs overlap the mitochondria. Time-lapse
confocal live-cell studies confirmed the association of NPs
with mitochondria. In Fig. 3B, the typical dynamics of mito-
chondria inside cells can be appreciated. The translational
motion and the bending of mitochondria are exactly followed
by associated NPs, resulting in a perfect colocalization in
space and time (see movie available as ESI “movie_mt-NPs”†).
Interestingly, traditional endocytosis does not seem to be
the uptake pathway taken by Pt-Ceria-8-atto NPs after short
incubation times. In the live-cell imaging study presented in
Fig. 4A, the cell plasma membrane was stained just before the
addition of NPs. Thus, new endosomes formed from the cell
surface (possibly enclosing NPs) were fluorescently marked.
Our results consistently showed no endosomal localization of
Pt-Ceria-8-atto NPs (here, only 1% of the NP signal overlaps
endosomes). The particles were instead distributed along with
the filament-like structures of the mitochondrial network, as
elucidated in Fig. 3. After relatively long incubation times,
however, the results were different. The peculiar uptake behav-
ior of the Pt-Ceria-8-atto NPs after 18 h of incubation time is
shown in Fig. 4B. Pt-ceria NPs do not only accumulate in mito-
chondria but also in lysosomes, the terminal vesicles that
receive the cargo from endosomes.39 On the whole, a mixed
uptake pathway was observed. Our findings points to the pres-
ence of two populations of particles in the sample: one popu-
lation that escapes the endocytic pathway, is rapidly
internalized, and accumulates in mitochondria; and another
population that follows traditional endocytosis, is less efficien-
tly internalized, and is delivered to lysosomes. Further
research has demonstrated that particle size is a crucial factor
determining the uptake mechanism of Pt-ceria NPs (see
below).
2.3 Mitochondrial targeting
As already emphasized, not only the fast NP uptake was
remarkable, but also the efficient and selective mitochondrial
targeting by Pt-Ceria-8-atto NPs. Targeting mitochondria with
Nanoscale Paper























































































lipophilic cations, such as triphenylphosphonium, has been
shown to be a successful strategy.40,41 Due to the large mito-
chondrial membrane potential, lipophilic cationic moieties
are attracted by and accumulate in mitochondria. Interestingly,
Atto 647N is also a lipophilic cationic dye with affinity to
mitochondria.42
In order to investigate if the mitochondrial-targeting pro-
perties observed for Pt-Ceria-8-atto NPs are an intrinsic ability
of Pt-ceria NPs, regardless of the attached fluorophores, we
prepared 8 nm Pt-ceria NPs labeled with perylenediimide (Pt-
Ceria-8-pery), a neutral and chemically quite inert fluorescent
dye.18 Missing the mitochondrial-targeting moieties, perylene-
diimide-labeled NPs would still be able to perform rapid cell
membrane penetration, but would not accumulate selectively
in mitochondria. Our hypothesis was confirmed by live-cell
confocal studies. HMEC-1 cells were incubated with cell
culture medium containing 50 µg mL−1 of either Pt-Ceria-
8-atto or Pt-Ceria-8-pery NPs for 2 h. Cells exposed to 50 µg mL−1
of Pt-Ceria-8-pery NPs presented a blurry cytosolic distribution
of NPs. In order to enhance the effect and optimize the visual-
ization, the concentration of the Pt-Ceria-8-pery NPs was
increased to 500 µg mL−1. As depicted in Fig. 5, both Pt-Ceria-
8-atto and Pt-Ceria-8-pery NPs were internalized by cells, but
while Atto 647N-labeled particles are mostly accumulated in
mitochondria, perylenediimide-labeled particles are clearly dis-
tributed throughout the cytosol. The fraction of Pt-Ceria-8-atto
NPs overlapping mitochondria for the upper cell in Fig. 5A is
86%. In contrast, the fraction of the Pt-Ceria-8-pery NPs over-
lapping mitochondria for the cell on the right in Fig. 5B is 46%.
Nevertheless, since perylenediimide-labeled NPs cover the entire
cytosolic region, 46% may be an overestimation caused by the
diffraction-limited signal of NPs that are not physically associ-
ated with mitochondria, but rather diffusely surrounding them.
The Atto 647N dye has therefore two functions in our model
NPs: labeling and mitochondrial targeting.
This comparison study indicates that only with the assist-
ance of a mitochondrial-targeting moiety (here, Atto 647N) the
selective mitochondrial localization of cytosolic NPs is pro-
moted. Since fluorescence microscopy relies on the use of
fluorophores to label the objects of interest, eventual dye
leakage or dye transfer to other objects may lead to misleading
interpretations. It is therefore worth emphasizing why the find-
ings presented in this work cannot be attributed to dye
leakage from NPs. First of all, perylenediimide and Atto 647N
are covalently bonded to the particle surface.18 Second, we
simulated the leakage of the Atto 647N dye from NPs in the
cell medium under comparable live-cell imaging conditions.
The outcomes were that free Atto 647N molecules are not able
to efficiently cross the plasma membrane of cells, and no
accumulation of the Atto 647N dye in the mitochondria was
Fig. 3 Live-cell imaging studies on the cellular uptake behavior of Pt-Ceria-8-atto NPs during a short interaction time. (A) Bright-field (left panel)
and confocal images of a representative HMEC-1 cell (dashed line) incubated with Pt-Ceria-8-atto NPs for 10 min. After this short period, a con-
siderable number of NPs (middle left panel, magenta) were internalized and accumulated in mitochondria (middle right panel, green: MitoTracker).
Note the high degree of colocalization (Manders’ overlap coefficient of 91%) in the merge image (right panel, white). Inset: boxed regions of con-
focal images in detail. Remarkably, the mitochondrial network and the distribution of Pt-Ceria-8-atto NPs are characterized by overlapping
filament-like structures. Scale bar = 10 µm. (B) Confocal image of another representative HMEC-1 cell with Pt-Ceria-8-atto NPs (magenta) associ-
ated with mitochondria (green; colocalizing pixels in white). Inset: time-lapse images of the boxed region. Note that the typical mitochondrial
dynamics (e.g. translational motion, bending, stretching) is perfectly followed by associated NPs with a complete colocalization in space and time
(see the ESI “movie_mt-NPs”†). Scale bar = 5 µm. Altogether, these results point to a very fast cellular uptake mechanism of Pt-Ceria-8-atto NPs, fol-
lowed by a selective NP attachment to mitochondria.
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observed (Fig. S1†). Finally, equivalent NPs lacking the decora-
tion with platinum or larger than ∼150 nm do not display any
mitochondrial localization, although labeled with Atto 647N
(see below).
2.4 Influence of platinum decoration
An effective investigation on the influence of only platinum
decoration requires NPs of similar properties, except for the
presence of platinum. For this purpose, we prepared the
samples Ceria-47-atto and Pt-Ceria-46-atto. They were syn-
thesized under aggregation control conditions and hold
similar properties (Table 1).
HMEC-1 cells were incubated with cell media containing
20 µg mL−1 of either Ceria-47-atto or Pt-Ceria-46-atto NPs,
washed and imaged afterwards. The results presented in Fig. 6
show the effect of ultrasmall platinum NPs (2–5 nm) on the
surface of ceria NPs. While Pt-Ceria-46-atto NPs are mostly
found distributed as filament-like structures that coincide with
the mitochondrial network (Fig. 6A), internalized Ceria-47-atto
NPs appear as punctate fluorescence patterns that characterize
the endocytosis uptake route (Fig. 6B). The same peculiar
uptake behavior of Pt-Ceria-8-atto NPs after long incubation
times (Fig. 4B) was observed for Pt-Ceria-46-atto NPs. Impor-
tantly, after very short incubation periods such as 20 min, Pt-
Ceria-46-atto NPs were already detected in mitochondria, but
Ceria-47-atto NPs were not even detected inside the cell (data
not shown). It was necessary to perform longer incubation
time experiments, such as 8 h, to detect reasonable amounts
of intracellular Ceria-47-atto NPs. In the present case, 83% of
mitochondria are overlapped by Pt-Ceria-46-atto NPs (Fig. 6A).
In contrast, only 4% of mitochondria are overlapped by Ceria-
47-atto NPs (Fig. 6B). In fact, a similar result (3%) was
measured for the signal of lysosomes overlapping mitochon-
dria in Fig. 4B. Such small values for the degree of colocaliza-
tion (Manders’ overlap coefficient) can therefore be attributed
to the proximity between vesicles and mitochondria in the
cytoplasm.
Hence, platinum decoration has an enormous influence on
the cellular uptake behavior of our model compounds for cata-
lyst-derived NPs. The presence of ultrasmall platinum NPs on
the surface of ceria NPs is a necessary condition for the
unusual uptake mechanism under investigation.
2.5 Influence of particle size
The influence of the particle core size on the uptake behavior
of catalyst-derived model NPs was investigated by comparison
studies with samples synthesized under aggregation control
conditions (see Fig. 2). Pt-ceria NPs of three distinct sizes were
prepared: 46 nm (Pt-Ceria-46-atto), 143 nm (Pt-Ceria-143-atto),
and 285 nm (Pt-Ceria-285-atto). Except for the determined
differences in the particle sizes, no other remarkable differ-
Fig. 4 Intracellular fate of Pt-Ceria-8-atto NPs after short and long interaction times. (A) Live-cell confocal images of a HMEC-1 cell (dashed line)
incubated with Pt-Ceria-8-atto NPs (left panel, magenta) for 20 min. Endosomes formed from the cell surface during the interaction with NPs were
fluorescently labeled (middle panel, yellow: WGA 488). Large amounts of Pt-ceria NPs were promptly internalized, and colocalization between NPs
and endosomes would mean an endocytic entry route. However, this does not seem to be the case for short incubation times, as illustrated in the
merge image (right panel, Manders’ overlap coefficient of only 1%). Inset: boxed regions in detail. Endosomes form a punctuate pattern, while Pt-
Ceria-8-atto NPs are distributed in the characteristic filament-like structures of the mitochondrial network. Note the lack of endosomal localization
of NPs. Scale bar = 5 µm. (B) Parallel experiments in which HMEC-1 cells (dashed line) were incubated with Pt-Ceria-8-atto NPs (left panel, red) for
18 h. Cellular lysosomes (middle left panel, cyan: LysoTracker) and mitochondria (middle right panel, green: MitoTracker) were stained before
imaging. Interestingly, some Pt-Ceria-8-atto NPs were accumulated in lysosomes (right panel, colocalizing pixels in white), while others in mito-
chondria (right panel, colocalizing pixels in yellow). Inset: boxed regions in detail. The filament-like structures of NPs associated with mitochondria
can be distinguished from the punctuate pattern of those NPs with lysosomal localization (arrow). Scale bar = 5 µm.
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ence in the physicochemical properties of the samples has
been noticed (Table 1).
Cellular uptake experiments parallel to those presented in
Fig. 6 were performed. The peculiar uptake behavior of the
46 nm Pt-ceria NPs is depicted in Fig. 6A. Crucially, the same
trend in the uptake mechanism was not observed for larger Pt-
ceria NPs. The results in Fig. 7 show that, although decorated
with platinum and labeled with Atto 647N, both Pt-Ceria-143-
atto and Pt-Ceria-285-atto NPs fail to associate with mitochon-
dria. Moreover, after short incubation times, such as 20 min,
no evidence of NP internalization was found (data not shown).
Intracellular NPs were only detected after longer incubation
times. After 8 h, a punctuate pattern of internalized Pt-Ceria-
143-atto and Pt-Ceria-285-atto NPs can be visualized (Fig. 7A
and B). As described previously, such a NP pattern distribution
is characteristic of particle endocytosis. The fraction of mito-
chondria overlapped by Pt-Ceria-143-atto and Pt-Ceria-285-atto
NPs was negligible (2% and 6%, respectively), and it can be
attributed to the signal overlapping of NPs inside endocytic
vesicles and neighboring mitochondria.
Taken together, the unusual uptake behavior observed for
46 nm Pt-ceria NPs was not observed for 143 and 285 nm Pt-
ceria NPs after short or long incubation times. These results
point to a remarkable particle size effect: Pt-ceria NPs smaller
than ∼50–100 nm escape the usual endocytic pathway and are
transported directly to the cytosol by a fast uptake process;
Pt-ceria NPs larger than ∼150 nm, by contrast, are taken up via
the conventional endocytosis route.
2.6 Inhibitor studies
After examining the influence of platinum decoration and par-
ticle size in the uptake behavior of Pt-ceria NPs, we investi-
gated whether endocytosis was involved in the fast uptake
mechanism observed. The most relevant and better under-
stood endocytic pathways are clathrin-mediated endocytosis,
caveolin-mediated endocytosis, macropinocytosis, and
phagocytosis.26–28 Generally, the functionality of distinct path-
ways is verified by live-cell imaging studies using specific
labeled substrates along with endocytic inhibitors.43–45 Trans-
ferrin glycoproteins, for example, are specifically and rapidly
internalized by the clathrin-mediated pathway, while sphingo-
lipid lactosylceramide molecules are exclusively and promptly
internalized in caveolae vesicles.36,39 Such fast uptake path-
ways, followed by sudden endosomal escape, would be poss-
ible mechanisms to deliver NPs directly into the cytosol.
Macropinocytosis and phagocytosis are relatively slow, as they
Fig. 5 Intracellular fate of 8 nm Pt-ceria NPs labeled with either Atto 647N or perylenediimide dyes. (A) HMEC-1 cells (dashed lines) were incubated
with Atto 647N-labeled NPs (Pt-Ceria-8-atto) for 2 h. The expected selective association of NPs (left panel, magenta) with mitochondria (middle
panel, green: MitoTracker) is evidenced in the merge image, with an overlap coefficient of 86% for the upper cell (right panel, white). Inset: boxed
regions in detail. Note the typical filament-like structures of colocalizing mitochondria and NPs. Scale bar = 5 µm. (B) Parallel experiments in which
HMEC-1 cells (dashed line) were incubated with perylenediimide-labeled NPs (Pt-Ceria-8-pery). A considerable amount of Pt-Ceria-8-pery NPs (left
panel, magenta) can be seen inside the cells. However, in contrast to the selective mitochondrial localization of Atto 647N-labeled NPs, perylene-
diimide-labeled NPs are mostly diffusely distributed in the cytoplasm region. The fraction of NPs overlapping mitochondria is 46% for the cell on the
right. Inset: boxed regions in detail. Note the massive presence of NPs in the cytosol and the absence of a selective accumulation in mitochondria.
Scale bar = 5 µm.
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are characterized by actin-driven protrusions from the plasma
membrane.27
In order to study the role of clathrin- and caveolin-depen-
dent endocytosis in the uptake of small Pt-ceria NPs, we per-
formed live-cell imaging in the presence of specific inhibitors.
First, the clathrin-mediated pathway of HMEC-1 cells was com-
pletely inhibited with 15 μg mL−1 chlorpromazine (CP) incu-
bated for 30 min and, after that, co-incubated transferrin was
no longer internalized. In a parallel experiment, cells with the
clathrin-mediated pathway completely blocked by CP were co-
incubated with Pt-Ceria-46-atto NPs (100 µg mL−1). A consider-
able amount of NPs was detected inside the cell after a short
incubation time of 20 min (Fig. S2†). Once inside the cells, Pt-
ceria NPs associated with mitochondria. These results indicate
that the clathrin-mediated endocytosis is not involved in this
uptake process. Next, we investigate the influence of caveolin-
mediated endocytosis. Caveolae vesicle formation depends on
the integrity of the actin network in the cell.46 It means that
actin disruption inhibits caveolin-mediated endocytosis (as
well as macropinocytosis and phagocytosis).27,47–49 For caveo-
lin-mediated endocytosis inhibition studies, cells were incu-
bated with cytochalasin D (CyD), a fungal toxin that promotes
actin depolymerization.49 CyD (5 µg mL−1) was added to
HMEC-1 cells 15 min prior to addition of Pt-ceria NPs and was
present in all biological media used throughout the experi-
ments. Inhibition of caveolin-mediated mechanism was con-
firmed by confocal imaging showing no internalization of
sphingolipid lactosylceramide molecules (LacCer). Finally,
cells with the caveolin-mediated pathway inhibited by CyD
were co-incubated with Pt-Ceria-46-atto NPs (100 µg mL−1).
The results presented in Fig. S3† demonstrate that NPs were
able to enter the cell and reach mitochondria within short
incubation times, such as 20 min. These results indicate that
the caveolin-mediated endocytosis as well as other actin-
dependent mechanisms are not involved in the uptake process
of small Pt-ceria NPs.
It is reported in the literature that cell membrane pene-
tration by ultrasmall NPs (e.g. 6–10 nm) is an energy-indepen-
dent process. Therefore, NP internalization occurs not only at
37 °C, but also with cells maintained at 4 °C.32,50 However,
these studies also show that the amount of internalized NPs is
typically drastically reduced at 4 °C. The reduced number of
internalized NPs is probably influenced by changes in the
mechanical properties of lipid bilayers at low tempera-
tures.51,52 To investigate the uptake behavior of small Pt-ceria
NPs at 4 °C we incubated HMEC-1 cells with Pt-Ceria-46-atto
(100 µg mL−1) on ice for 30 min. In our results, no internali-
zation of Pt-ceria NPs at 4 °C was detected (data not shown).
Fig. 6 Influence of platinum decoration on the cellular uptake behavior of ceria NPs. (A) Live-cell confocal images of a representative HMEC-1 cell
(dashed line) incubated with Pt-Ceria-46-atto NPs (left panel, magenta) for 8 h. Cellular mitochondria (middle panel, green: MitoTracker) were
stained prior to imaging. Note that NPs displaying a filament-like structure colocalize with mitochondria, while punctuate NPs do not (right panel,
white pixels). Here, NPs overlap 83% of mitochondria. (B) Parallel experiments in which HMEC-1 cells (dashed lines) were incubated with Ceria-
47-atto NPs (left panel, magenta). Remarkably, only the punctuate pattern of NPs, characteristic of the endocytic pathway and vesicle localization,
can be observed. Moreover, no evidence of colocalization between mitochondria (middle panel, green: MitoTracker) and NPs was detected in the
merge image (right panel, Manders’ overlap coefficient of 4%). Inset: boxed regions in detail. Scale bars = 5 µm.
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Yet, upon warming of cells back to 37 °C, fast internalization
of NPs occurred. The observed inhibition of Pt-ceria NP uptake
at 4 °C may have been influenced by the core sizes of our par-
ticles (see Table 1), which are significantly larger than the
abovementioned ultrasmall NPs. We hypothesize that Pt-ceria
NPs are not able to translocate membranes at 4 °C due to
changes in the elastic properties of cell membranes at low
temperatures.
2.7 Protein corona
NPs are normally covered by a protein corona as they interact
with proteins present in biological media. The protein corona
can largely define the biological identity of a given NP, and it
can therefore influence the effect of this NP on a cellular
level.53 The results described so far have all been obtained
with cell media supplemented with 10% fetal bovine serum
(FBS). With the purpose of verifying if the presence of serum
proteins in cell culture medium plays a decisive role in the
interaction between Pt-ceria NPs and cells, we incubated
HMEC-1 cells with Pt-Ceria-46-atto NPs (100 µg mL−1) in a cell
medium formulation free of FBS. Interestingly, the outcomes
were not distinct from those measured in the presence of
serum proteins, and NPs were found inside the cells and
associated with mitochondria (Fig. S4†). Thus, the presence of
serum proteins (in solution or forming a protein corona
adsorbed to the NP surface) does not influence the unusual
uptake behavior observed for small Pt-ceria NPs. These results
indicate an uptake mechanism driven by the physicochemical
properties of the bare surface of NPs. In addition, these results
are in line with the cell membrane penetration by ultrasmall
gold NPs in both serum-free and serum-containing cell
medium.32
2.8 Cell membrane integrity
So far, all results point toward cell membrane penetration by
small Pt-ceria NPs. Cell membrane penetration by NPs can
cause the disruption of the plasma membrane and induce
cytotoxic effects.54 In addition, the leakage of ions or mole-
cules into or out of the cell through permanent holes on the
membrane can lead to cell death.32 To verify whether Pt-ceria
NPs cause permanent holes or any other damage to the
plasma membrane integrity, we performed calcein leakage in
and out assays.
First, we tested if the direct translocation of Pt-ceria NPs
through the membrane was accompanied by the leakage in (or
penetration) of co-incubated calcein. The fluorescent dye
calcein cannot penetrate an intact cell membrane directly, but
is normally internalized by endocytosis and remains enclosed
by intracellular vesicles. However, if the membrane is dis-
rupted, calcein can penetrate the cell and a diffuse pattern is
Fig. 7 Influence of particle size on the cellular uptake behavior of Pt-ceria NPs. Live-cell confocal images of HMEC-1 cells (dashed lines) incubated
with either (A) Pt-Ceria-143-atto NPs or (B) Pt-Ceria-285-atto NPs for 8 h. Similar results were achieved with both samples, and a punctuate pattern
typical of particle endocytosis was observed (left panels, magenta). In addition, the absence of NP accumulation in mitochondria (middle panels,
green: MitoTracker) can be noticed in the merge images (right panels). The fraction of Pt-Ceria-143-atto and Pt-Ceria-285-atto NPs overlapping
mitochondria is only 2% and 6%, respectively. Such small values can be attributed to the signal of NPs in endosomes overlapping nearby mitochon-
dria. Insets: boxed regions in detail. Note the punctuate pattern of NPs distributed in the vicinity, but not in mitochondria. Scale bars = 5 µm.
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observed throughout the cytosol. Scoring the percentage of cells
without the cytosolic calcein distribution is a convenient way to
access the viability of cells after exposure to external agents. Cell
membrane damage caused by external agents is typically charac-
terized by the majority of cells exhibiting cytosolic calcein. For
example, Verma et al.32 showed that cationic gold NPs (coated
with 11-mercaptoundecane-tetramethylammonium chloride)
which are able to disrupt membranes, led to cytosolic calcein
distribution in ∼50% of the dendritic cells, while in the control
samples not treated with gold NPs, 95% of the cells were found
without calcein cytosolic distribution.
We co-incubated HMEC-1 cells with cell medium contain-
ing 0.1 mg mL−1 calcein and 100 µg mL−1 Pt-Ceria-46-atto NPs
for 3 h. After this, cells were washed and imaged live. The per-
centage of cells without calcein distribution was above 97%.
Besides, no significant difference in the viability of untreated
and NP treated cells was found (Fig. S5†).
Next, we performed complementary studies on the particle-
induced leakage out (or release) of previously internalized cyto-
solic calcein. The cell-permeant and nonfluorescent calcein-AM
dye can access the cytosolic compartment of living cells and,
once there, it is converted to the fluorescent calcein by intra-
cellular esterases and remains trapped in the cytosol. In our
experiments, HMEC-1 cells were preincubated with 5 µM
calcein-AM for 45 min. Calcein-loaded cells were washed with
cell medium and incubated with 100 µg mL−1 Pt-Ceria-46-atto
NPs for 0.5 and 3 h. After the respective incubation periods,
cells were washed again and imaged live. The mean fluorescence
intensity of cytosolic calcein was measured in untreated cells
and in cells treated with Pt-ceria NPs (Fig. S6†). The data show
that no leakage out of pre-loaded cytosolic calcein was induced
by the uptake of NPs. Moreover, no significant difference
between untreated and NP treated cells was detected. These
results are in line with the previous findings on the leakage in of
calcein (Fig. S5†). Altogether, calcein leakage in and out assays
offer supporting evidence that small Pt-ceria NPs can access the
cytosol without causing noticeable membrane disruption.
2.9 Impact of ceria and Pt-ceria NPs on the cellular ATP level
In order to further investigate if small Pt-ceria NPs can have an
impact on cellular viability, we measured and compared the
particle-induced cytotoxicity of (non-labeled) Ceria-47, Pt-
Ceria-46, and Pt-Ceria-143 NPs. HMEC-1 cells were incubated
at two distinct concentrations: 10 µg mL−1 and 100 µg mL−1.
After specific incubation periods of 3, 24, 48 and 72 h, the rela-
tive adenosine triphosphate (rATP) content was analyzed to
assess the metabolic impact of NPs on cells. One hundred
percent rATP content represents the cellular viability of
untreated cells. As presented in Fig. 8, the rATP contents of
cells treated with Pt-Ceria-46 NPs do not significantly differ
from the rATP values of cells incubated with either Ceria-47 or
Pt-Ceria-143 NPs. In addition, there is no significant difference
in the cytotoxicity of non-labeled and Atto 647N labeled 46 nm
Pt-ceria NPs (100 µg mL−1; Fig. 8B). This means that platinum
decoration and the unconventional uptake mechanism of Pt-
Ceria-46-atto NPs do not induce a different nanotoxicity under
the investigated conditions. Moreover, the rATP values were
found to be above the cytotoxic threshold of 70% (dashed line)
under all investigated conditions. This is a clear indication
that ceria and Pt-ceria NPs are well tolerated by HMEC-1 cells
in short-term exposure experiments (3–72 h).
2.10 Cell-penetrating Pt-ceria NPs
As described in the literature, cell-penetrating peptides,29
quantum dots,30 and ultrasmall noble metal NPs (<∼10 nm),
such as gold31–35 and platinum,36,37 can escape the endocytic
pathway and translocate the plasma membrane into the
cytosol. This unconventional pathway is characterized by fast
and efficient cellular uptake, no perceptible cell membrane
Fig. 8 Cellular viability of cells treated with ceria and Pt-ceria NPs.
HMEC-1 cells were exposed to either (A) 10 µg mL−1 or (B) 100 µg mL−1
of distinct NP samples: Ceria-47 NPs (white bars), Pt-Ceria-46 NPs (light
gray bars), Pt-Ceria-143 NPs (dark gray bars), and Pt-Ceria-46-atto NPs
(light gray striped bars). The incubation time extended from 3 to 72 h.
Within this time, no significant difference (p < 0.01) was detected in the
relative adenosine triphosphate (rATP) content of cells exposed to any
NP type (in comparison to the other NP types). In addition, the rATP
content measured was always above the cytotoxicity threshold of 70%
(dashed line, cytotoxicity according to DIN EN ISO 109935:2009-10).
This means that the metabolic impact induced by all these NP types on
HMEC-1 cells was quite low. Histograms represent the mean ± standard
error from three independent experiments.
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disruption and low cytotoxic effects.31 This description almost
perfectly matches our findings on the unusual fast uptake
mechanism and cytosolic delivery of small Pt-ceria NPs. The
exception is the presence of a relatively large ceria NP core.
So as to test the generality of our results, we prepared 8 nm
ceria NPs decorated with other noble metals; namely, rhodium
and palladium. In addition, we synthesized platinum-deco-
rated 50–80 nm mesoporous silica NPs. Preliminary results
indicate that in all cases the same trend, with cell membrane
penetration and mitochondrial targeting by Atto 647N-labeled
NPs was achieved (data not shown). Moreover, we investigated
if the uptake trend observed for small Pt-ceria NPs is cell-type
dependent. Human cervical cancer cells (HeLa) were incubated
with Pt-Ceria-8-atto NPs, and the same unusual uptake behav-
ior observed before was observed for HeLa cells (Fig. S7†).
In order to gain more information regarding the cell mem-
brane penetration and mitochondrial association of Pt-ceria
NPs we performed transmission electron microscopy (TEM) of
cells. First, HeLa cells were incubated with non-labeled
(Pt-Ceria-46) as well as Atto 647N-labeled particles (Pt-Ceria-
46-atto) for 2 h. Subsequently, specimens were fixed, dehydrated,
infiltrated, embedded, cured, cut in thin sections of 80–90 nm,
mounted, stained, and finally examined by TEM (for details
see section 3.4). Remarkably, the results presented in Fig. 9A
are in line with the hypothesis of cell membrane penetration
of small, individual Pt-ceria NPs as well as conventional endo-
cytosis of particle aggregates. In addition, the micrograph
shown in Fig. 9B suggests the accumulation of targeted NPs
(Pt-Ceria-46-atto) on the outer membrane of mitochondria.
Yet, the production of the TEM micrographs of cells relies on
standard but quite elaborated fixation, staining, embedding
and ultrathin sectioning protocols that may create artifacts.
These TEM images should therefore be interpreted with care
and regarded as an indication of the presence of Pt-ceria NPs
in the respective cellular compartments, as thoroughly shown
by the live-cell imaging results presented in this work.
On the basis of our findings and the literature, we propose
the following uptake mechanism for small Pt-ceria NPs: as one
NP diffuses and approaches a cell, the ultrasmall platinum
NPs on its surface generate multiple transient nanoscale
holes. These holes combine and allow the membrane pene-
tration of the NP up to a core size of ∼50–100 nm. After the
passage of the particle, the membrane rapidly reseals itself.
Once inside the cells, the diffusing NP will come into contact
with cell organelles and, in the case of Pt-ceria NPs labeled
with Atto 647N, will attach to mitochondria owing to the lipo-
philic cationic moieties of this dye. Fig. 10 illustrates graphi-
cally the cell membrane penetration and mitochondrial
targeting by a 50 nm Pt-ceria NP.
3. Experimental details
3.1 Synthesis and characterization of ceria and Pt-ceria NPs
The influence of the reaction parameters on the synthetic pro-
cedures is discussed by Herrmann et al.,18 and experimental
Fig. 9 TEM images of Pt-ceria NPs of 46 nm internalized by HeLa cells.
Electron micrographs of thin transverse sections (80–90 nm) (A) indicat-
ing the presence of non-labeled Pt-Ceria-46 in the cytosol (black
arrows), in endosomes (white arrows), and on the plasma membrane
(open arrow) and (B) suggesting the accumulation of Pt-Ceria-46-atto
on the outer surface of mitochondria (black arrows).
Fig. 10 Cell membrane penetration and mitochondrial targeting by Pt-ceria NPs. Within a few minutes of incubation time, three mitochondria-
targeted NPs approach a cell: (a) 50 nm Pt-ceria NP, (b) 50 nm ceria NP, and (c) 150 nm Pt-ceria NP. In the case of particle (a), ultrasmall platinum
NPs decorating its surface induce nanoscale holes on the cell membrane, and the NP directly translocates from the extracellular environment into
the cytosol. Particle (b) is not able to translocate the membrane because it is free of ultrasmall platinum NPs on its surface. Particle (c) is too large to
pass through eventually induced holes. After translocation, particle (a) diffuses freely in the cytosol and the membrane reseals. Next, the diffusing
NP reaches and attaches to a mitochondrion. After a few hours, the particles (b) and (c) are internalized by the conventional endocytic pathway and
remain trapped in vesicles.
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details are given here. Deionized water and dry ethanol
(Emsure quality, Merck) were used for all syntheses.
Ceria NPs. The procedure was adapted from that used by Yu
et al.55 Ce(NO3)3·6H2O (2.0 mmol, 870 mg) was dissolved in a
mixture of 18 mL of ethanol and 1 mL of water. The solution
was heated in a round bottom flask (not covered, needs
contact with air) to 70 °C under stirring. Ammonia (25%) was
added in one portion (1.0 mL). A thick precipitate formed
which became a slightly yellowish suspension after stirring for
2 hours. Care had to be taken as the solvent did not evaporate
during this time. After cooling to room temperature, stirring
was continued for ca. 15 h. The resulting particles were separ-
ated by centrifugation (9500g, 15 min), and washed three
times with water (12 mL) and three times with ethanol
(12 mL), each step consisting of redispersion by ultrasound
treatment in the appropriate solvent and centrifugation under
the same conditions as before. The product, ceria NPs of 8 nm
average diameter, was stored in ethanol.
Controlled aggregation of ceria NPs. The procedure was
adapted from that described by Wang et al.56 A 4 mL screw cap
glass vial with a Teflon gasket (Wheaton) was charged with
Ce(NO3)3·6H2O (99%, Sigma-Aldrich) and poly(vinylpyrrolidone)
(PVP), average Mw 55 000 (Sigma-Aldrich), dissolved in a
mixture of water and ethanol. The vial was tightly closed and
stirred at an appropriate oil bath temperature for the time indi-
cated. After cooling to room temperature the nanoparticles
were isolated by centrifugation and washed with water
(3 times, 2 mL) and ethanol (3 times, 2 mL) as described
before. The amounts of the starting material and the reaction
conditions are given in Table 2 (compare Table 1).
Platinum decoration of ceria NPs. To a ceria nanoparticle
dispersion in ethanol (20 mg in 0.5 mL) in a 4 mL screw cap
glass vial with a Teflon gasket (Wheaton) the precursor
K2PtCl4, dissolved in 3 mL of water, was added. The vial was
closed and the reaction mixture was stirred at 70 °C (oil bath
temperature) for 17 h. After cooling, solid KBH4 (ca. 5 mg) was
added (caution: foaming) and stirring continued for 1 h at
room temperature. The particles were isolated by the centrifu-
gation procedure and washed with water (3 times, 2 mL) and
ethanol (3 times, 2 mL) as described before. The product was
stored in ethanol.
Labeling with fluorescent dyes. The perylenediimide marker
(MPD-APS) was prepared as described by Blechinger et al.57
The Atto 647N marker (Atto 647N-APS) was obtained from a
commercial Atto 647N NHS ester (Sigma-Aldrich) by reaction
with 3-(triethoxysilyl)propylamine (APS). Thus, the NHS ester
(0.85 mg, 1 µmol) in 80 µL of N,N-dimethylformamide was
added to a solution of APS (1 µmol mL−1) in ethanol (1.5 mL)
and stirred for 5 h at room temperature. Thin layer chromato-
graphy (silica, chloroform/ethanol 1 : 1) showed complete con-
version (NHS ester: retardation factor Rf 0.81, Atto 647N-APS:
Rf 0.87). The solution was stored at 5 °C in the dark and used
without further purification for nanoparticle labeling. To the
nanoparticle dispersion (20 mg) in ethanol (1.5 mL) was added
100 µL of the Atto 647N-APS solution, or 50 µL of MPD-APS
(15 µmol mL−1 in chloroform), respectively, and the mixture
was stirred in a closed screw cap vial (Wheaton) for 5 h at
120 °C (oil bath temperature); for MPD-APS, 140 °C was
applied. Stirring was continued for 20 h at room temperature.
The labeled particles were isolated by centrifugation and puri-
fied by redispersion in ethanol and centrifugation (4 times,
2 mL) as described before. The particles were stored in ethanol
in the dark.
Transmission electron microscopy (TEM) and energy-disper-
sive X-ray (EDX) spectroscopy. TEM and EDX images were
obtained with a JEM 2100 F (JEOL) instrument. Nanoparticle
dispersions were diluted with ethanol and applied onto
carbon-coated copper grids (Formvar coal-film on a 200 mesh
net; Plano GmbH). Particle sizes were determined from TEM
images by digital image analysis using the ImageJ software.58
Particle size distribution and zeta potential determinations.
Dynamic light scattering (DLS) measurements were employed
to determine the intensity weighted mean hydrodynamic dia-
meter of the ceria and Pt-ceria NPs. Investigations on the
electrophoretic mobility of the nanoparticles were carried out
to determine the zeta potential. Both studies were conducted
with Zetasizer Nano equipment (Malvern Instruments) on col-
loidal NP suspensions in either ethanol or in cell medium sup-
plemented with 10% FBS (incubation time of 30–40 min).
3.2 Incubation of cells with NPs
Cell culture. HMEC-1 cells (Centers for Disease Control and
Prevention, USA) were grown in Gibco MCDB 131 medium sup-
plemented with 10% fetal bovine serum (FBS), 1% GlutaMAX-I
(100X), 10 ng mL−1 human epidermal growth factor (all pur-
chased from Life Technologies), and 1 µg mL−1 hydrocortisone
(Sigma-Aldrich). HeLa cells were grown in Gibco Dulbecco’s
modified Eagle’s medium (DMEM; Life Technologies,
Germany) supplemented with 10% FBS. Cells were maintained
at 37 °C under a humidified atmosphere containing 5% CO2.
Redispersion of NPs in cell medium. Dispersions of ceria
NPs and Pt-ceria NPs were prepared in the same cell medium
used for cell growth according to the following procedure:
first, the stock dispersion of NPs (in ethanol) was vortexed for
10 s, treated with an ultrasonic bath for 10 min, and vortexed
again for 10 s; next, a small aliquot (up to a few µL) of the
Table 2 Starting material and reaction conditions
Sample Ce(NO3)3·6H2O [mg] PVP [mg] Ethanol [mL] Water [mL] Temperature [°C] Time [h]
Ceria-47 56 216 1.5 0.5 140 6
Ceria-143 108 56 1.5 0.5 130 20
Ceria-285 108 56 0.67 1.34 140 13
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ethanolic suspension of NPs was added into a microcentrifuge
tube (1.5–2 mL; Eppendorf); ethanol was then left to evaporate
completely under a laminar flow or under a gentle stream of
N2; after complete evaporation of ethanol, the tube with the
dried NPs was closed and reserved for up to 6 hours; shortly
before addition to cells, a given volume of cell medium (so as
to reach the desired NP concentration) was added to the dried
NPs in the tube; finally, particles were immediately dispersed
in the medium by sonication, warmed up to 37 °C, and added
to cells.
Uptake experiments. For live-cell imaging experiments, cells
were seeded 24 h before imaging in Lab-Tek II 8-well chamber
slides (Thermo Fisher Scientific Inc.) in a density of 1.2 × 104
cells per cm2. HMEC-1 cells were incubated with NPs at 37 °C
under a humidified atmosphere containing 5% CO2.
Uptake kinetics, intracellular fate, and mitochondrial target-
ing. Cell plasma membranes were stained with a wheat germ
agglutinin Alexa Fluor 488 conjugate (WGA 488, 10 µg mL−1 in
cell medium for 1 min) or with CellMask Orange (0.05% (v/v)
in cell medium for 1–2 min). Mitochondria were stained with
MitoTracker Green FM (100 nM in cell medium for 15–30 min)
or with MitoTracker Red CMXRos (60 nM in cell medium for
10 min). Cellular lysosomes were stained with LysoTracker Red
(150 nM in cell medium for 30 min; all organelle-specific
stains were purchased from Life Technologies). In all cases,
after the indicated incubation times, the respective staining
solution was removed and cells were washed twice with warm
cell medium. Cell medium containing the NPs was then added
to cells. Cells were imaged live as described below.
Inhibitor studies. To investigate if endocytosis was involved
in the fast uptake behavior of Pt-ceria NPs, inhibition studies
were conducted. To ensure a complete inhibition of the cla-
thrin-dependent uptake pathway, HMEC-1 cells were incubated
with 15 µg mL−1 chlorpromazine (Sigma-Aldrich) for 30 min
prior to addition of further substrates. To probe the clathrin-
mediated endocytosis, inhibited cells were then co-incubated
with transferrin (20 µg mL−1; Life Technologies) or Pt-ceria
NPs (100 µg mL−1) for 20 min. To visualize the uptake, the cell
membrane was stained with CellMask Orange (as described
above, but in cell medium containing 15 µg mL−1 chlorproma-
zine). Live-cell imaging was performed in the presence of the
inhibitor, except for the uptake of transferrin in the absence of
chlorpromazine, as shown in Fig. S2A.† The caveolin-depen-
dent mechanism was efficiently inhibited with 5 µg mL−1 cyto-
chalasin D (CyD; Sigma-Aldrich). HMEC-1 cells were incubated
with CyD for 15 min prior to addition of further substrates. To
investigate the caveolin-mediated pathway, inhibited cells were
co-incubated with 0.5 µM sphingolipid lactosylceramide
(LacCer; Life Technologies) or Pt-ceria NPs (100 µg mL−1) for
20 min. All experiments were performed in the presence of the
inhibitor, except for the uptake of LacCer in the absence of
CyD (Fig. S3A†).
Cell membrane integrity. For calcein leakage in (or pene-
tration) assay, HMEC-1 cells were co-incubated with cell
medium containing 0.1 mg mL−1 calcein (Life Technologies)
and 100 µg mL−1 of Pt-ceria NPs for 3 h. After the incubation
time, cell plasma membranes were stained with CellMask
Orange (see above) and imaged as described below. For calcein
leakage out (or release) assay, HMEC-1 cells were preincubated
with 5 µM calcein-AM (Life Technologies) for 45 min. Calcein-
loaded cells were then washed with cell medium and incu-
bated with 100 µg mL−1 of Pt-ceria NPs for 0.5 and 3 h. After
the respective incubation periods, cells were washed again and
imaged live.
Colocalization studies. Manders’ overlap coefficients were
determined by using the ImageJ plugin JACoP developed by
Bolte and Cordelieres.38
Cytotoxicity studies. For cytotoxicity evaluation (see below),
1.2 × 104 HMEC-1 cells per cm2 were seeded in 96-well cell
culture plates. 24 h after seeding, cells were exposed to either
ceria NPs or Pt-ceria NPs dispersed in cell medium (as
described above) at 37 °C under a humidified atmosphere con-
taining 5% CO2.
3.3 Live-cell imaging
Spinning disk confocal microscopy was performed on a setup
based on the Zeiss Cell Observer SD equipped with a Zeiss
Plan Apochromat 63×/1.40 Oil/DIC objective. Samples were
maintained at 37 °C under a 5% CO2 atmosphere during
imaging and were illuminated with laser light alternating
between 488 nm (exciting WGA 488, MitoTracker Green, peryle-
nediimide, calcein, or LacCer), 561 nm (exciting CellMask
Orange, MitoTracker Red, or LysoTracker Red), and 639 nm
(exciting Atto 647N). The emission signal was split by using a
dichroic mirror at 560 nm (for dual-color detection upon exci-
tation with 488 or 639 nm light) or at 660 nm (for three-color
detection upon excitation with 488, 561 or 639 nm light).
Separate images for each fluorescence channel were sequentially
acquired using two separate electron multiplier charge-
coupled device cameras (Evolve 512; Photometrics). The band-
pass detection filters of the first camera, installed in an auto-
matic revolving filter wheel, were 525/50 nm (WGA 488/
MitoTracker Green/perylenediimide/calcein/LacCer channel)
and 629/62 nm (CellMask Orange/MitoTracker Red/Lyso-
Tracker Red channel). The bandpass filter used for the second
camera was 690/50 nm (Atto 647N channel). Exposure times
were set to 100–500 ms. The Z-stacks of single cells were
imaged with an interslice distance of 250 nm.
3.4 Characterization of nanoparticle uptake using TEM
TEM specimen preparation (fixation, dehydration, infiltration,
embedding, curing, thin sectioning, mounting and staining)
of cells incubated with Pt-ceria NPs was performed using stan-
dard procedures as follows: HeLa cells were cultivated as
described above and seeded onto Falcon cell culture inserts
(high pore density translucent PET membranes with a pore
size of 0.4 µm; Corning) placed into a companion Falcon 24-
well culture plate. The lower compartments of the wells were
filled with prewarmed culture medium (700 µL) and cells were
seeded onto the inserts at a density of 6.6 × 104 cells per cm2
(200 µL). After 24 h incubation with cell medium, dispersions
of the Pt-ceria NPs prepared as described before (see section
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3.2) were added to the cells. HeLa cells were incubated with
NPs (100 µg mL−1) for 2 h at 37 °C under a humidified atmo-
sphere containing 5% CO2. Cells were fixed overnight with a
half strength Karnovsky’s fixative (2.5% paraformaldehyde,
3.0% glutaraldehyde, and 0.06% calcium chloride in 0.1 M
cacodylate buffer) at 4 °C. Here and in the following steps
using the cell culture inserts, 200 µL of the working solution
were added to the top and 700 µL to the bottom chamber.
After fixation cells were washed (3 times, 15 min) with 0.1 M
cacodylate buffer (Morphisto GmbH) and then placed for 6 h
with 0.1 M cacodylate buffer at 4 °C. Next, cells were post-fixed
for 2 h at 4 °C with a solution containing 1% osmium tetroxide
(Sigma Aldrich) and 1.5% potassium ferrocyanide (Carl Roth)
in 0.1 M cacodylate buffer (freshly prepared using one part of
a 2% osmium tetroxide solution and another part of a 3%
potassium ferrocyanide solution). Cells were washed with 0.1 M
cacodylate buffer (3 times, 15 min and then overnight at 4 °C).
Next day cells were washed with PBS (15 min) and the mem-
branes containing the cells were removed from the inserts
using a sharp razor blade. The membranes were then placed
into individual microcentrifuge tubes (1.5 mL; Eppendorf) and
dehydration of the cells was performed under slight agitation
(300 rpm; Thermomixer Comfort, Eppendorf) in a graded
ethanol series at RT (1 mL; 30%, 50%, 70%, 20 min each;
95%, 30 min; and 100% 3 times, 30 min). For embedding we
used the Poly/Bed 812 Embedding Kit (Polyscience). Prior to
embedding cells were infiltrated at RT in four steps with a pro-
pylene oxide/embedding mixture (1 mL; twice 1 : 0, 15 min;
then 2 : 1, 1 : 1 and 0 : 1, 1 h each). Infiltration was performed
under slight agitation (300 rpm, Thermomixer Comfort;
Eppendorf). The membranes were transferred from the tubes
(containing 100% embedding medium) to embedding molds
(Plano GmbH, cat. no. G369N). Molds containing the mem-
branes were filled with embedding medium and cured at 60 °C
for 30 h. Afterwards, ultrathin sections of 80–90 nm thickness
were cut using a ultramicrotome (Leica-Reichert Ultracut E),
mounted onto copper grids (Formvar-carbon 300 mesh; Ted
Pella, Inc.) and stained with uranyl acetate (8% for 10 min)
and Reynold’s lead citrate solution (2.2% for 3 min). Finally,
specimen sections were examined on a transmission electron
microscope (JEM 1011, JEOL).
3.5 Cytotoxicity studies
To assess the relative cellular ATP content, cells were seeded as
described above. The culture medium was then replaced with
a fresh one containing either 10 µg mL−1 or 100 µg mL−1 of
NPs. After defined incubation times (3, 24, 48, and 72 h), cells
were washed with Hank’s balanced salt solution. Next, Cell-
Titer-Glo Luminescent Cell Viability Assay (Promega GmbH) was
used according to manufacturer’s instructions. The relative
ATP content of the cells was calculated from the measured
luminescence (LUMIStar Galaxy; BMG LABTECH GmbH) and
expressed as the relative value compared to untreated control
cells. To interpret the impact of the ceria NPs as well as Pt-
ceria NPs on endothelial cells, the threshold for cytotoxicity
according to DIN EN ISO 10993-5:2009-10 was considered.
3.6 Statistical analysis
For statistical analysis, the unpaired Student’s t-test was used.
The values were expressed as the mean ± standard error. The
results were considered as statistically different at p < 0.05 and
highly statistically different at p < 0.01.
4. Conclusions
In summary, platinum-decorated ceria NPs that resemble cata-
lyst-derived particles can escape the traditional endocytosis
uptake pathway and perform a rapid and direct translocation
through the cell membrane. Interestingly, similar ceria NPs
free of platinum do not translocate through the membrane,
but are internalized by endocytosis. In addition, the particle
size is a crucial parameter – only Pt-ceria NPs smaller than
∼50–100 nm are able to perform cell membrane penetration. If
suitably targeted, these NPs are able to selectively attach to cel-
lular organelles like mitochondria. Mitochondrial targeting
was achieved at first by chance with Atto 647N, a fluorescent
dye with high affinity to this cell organelle.
The results presented in this work make distinguished con-
tributions to the fields of nanotoxicology and nanomedicine.
As regards nanotoxicology, although the uptake mechanism
proposed involves the fast translocation of Pt-ceria NPs into
the cytosol, our findings suggest that the short-term nanotoxico-
logy of high doses of Pt-ceria NPs (within 72 h, 100 µg mL−1)
is rather low. However, long-term effects of continuous
exposure to much lower doses, as in human exposure to air
pollution, remain to be investigated. With respect to nano-
medicine, Pt-ceria NPs (and conceivably other noble-metal
decorated NPs) are fascinating materials that can rapidly and
efficiently enter cells and reach intracellular organelles, such
as mitochondria. In this way they represent an interesting par-
ticle type with high potential to become important platforms
for intracellular-targeted drug and gene delivery.
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